查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1760030

2025年生物技術人工智慧全球市場報告

AI In Biotechnology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年，生物技術領域的人工智慧市場規模將呈指數級成長。到 2029 年，該市場規模將成長至 134 億美元，複合年成長率為 24.6%。預測期內的成長可以歸因於人工智慧技術的普及、人工智慧生物企業投資的增加、人工智慧在毒理學研究中的應用不斷成長、人工智慧主導的癌症研究中預測模型的出現，以及人工智慧主導的藥物再利用領域的擴展。這段時期預計的主要趨勢包括深度學習和神經網路的發展、人工智慧與基因組學和蛋白​​質組學的整合、人工智慧主導的CRISPR 基因編輯的進步、人工智慧在藥物安全檢測中的應用，以及基於人工智慧的伴隨診斷的開發。

人工智慧 (AI) 的日益普及預計將推動生物技術領域 AI 市場的擴張。 AI 指的是模擬人類認知功能以執行學習、推理和解決問題等任務的機器，尤其是電腦系統。 AI 的日益普及得益於其能夠提高各行各業的效率、準確性和決策能力，尤其是能夠以高精度自動化複雜數據分析。在生物技術領域，AI 可以顯著加速藥物研發，簡化研究流程，並增強預測模型，最終有助於改善醫療保健結果。例如，2024年10月，英國科學、創新與技術部（DSIT）報告稱，人工智慧活動顯著成長，其中2023年人工智慧公司數量成長17%（新增543家），人工智慧創造的收益成長34%（新增36億英鎊），就業崗位成長29%（新增1.45萬人），總增加價值202億英鎊（GVA257%），總增加127億英鎊增加25億英鎊），總增加127億英鎊增加25億英鎊增加25億英鎊），總增加127億英鎊增加25億英鎊增加25億英鎊），總增加價值25億英鎊增加25億英鎊（293億英鎊新增25億英鎊），附加價值毛額29%（新增1.45億英鎊），總增加價值21億英鎊增加25億英鎊（新25億英鎊），總增加價值25億英鎊增加25億英鎊增加25億英鎊），總增加120億英鎊增加25億英鎊。因此，人工智慧的日益普及正在推動人工智慧主導的生物技術市場的成長。

為了鞏固市場地位，生物技術領域的主要企業正優先開發先進技術，例如基於人工智慧的抗體發現平台。這些平台利用人工智慧高效識​​別和最佳化治療性抗體，加速藥物開發，同時降低成本並改善臨床療效。例如，2023年2月，以色列創投工作室AION Labs推出了DenovAI，這是一個致力於從頭發現治療性抗體的創新平台。此尖端系統整合了機器學習和計算生物物理學，用於識別高親和性候選抗體，從而提高了序列多樣性、準確性並縮短了開發週期。 DenovAI代表了生物技術領域的重大飛躍，它促進了更快、更經濟的藥物發現，並提高了在各個疾病領域臨床成功的幾率。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球生物技術領域人工智慧的 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球生物技術人工智慧市場：成長率分析
  • 全球生物技術人工智慧市場表現：規模與成長，2019-2024
  • 全球生物技術人工智慧市場預測：2024-2029 年及 2034 年規模與成長
  • 生物技術領域的全球人工智慧總可尋址市場 (TAM)

第6章市場區隔

  • 全球生物技術市場人工智慧的組成部分、表現與預測（2019-2024、2024-2029、2034）
  • 軟體
  • 硬體
  • 服務
  • 全球生物技術市場人工智慧的應用、表現和預測（2019-2024 年、2024-2029 年和 2034 年）
  • 藥物研發
  • 臨床試驗和最佳化
  • 醫學影像
  • 診斷
  • 其他用途
  • 全球生物技術市場人工智慧最終用戶、績效及預測（2019-2024、2024-2029、2034）
  • 製藥公司
  • 生技公司
  • 學術研究所
  • 醫療保健提供者
  • 合約研究組織 (CRO) 和合約開發與製造組織 (CDMO)
  • 其他最終用戶
  • 全球生物技術人工智慧市場：軟體細分、類型、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 以人工智慧為基礎的數據分析工具
  • 機器學習演算法
  • 生物資訊軟體
  • 藥物研發平台
  • 臨床試驗管理軟體
  • 全球生物技術市場人工智慧、硬體細分、類型、性能和預測（2019-2024 年、2024-2029 年、2034 年）
  • 高效能運算（HPC）系統
  • AI一體化影像設備
  • 資料儲存解決方案
  • 實驗室自動化設備
  • 穿戴式健康監測設備
  • 全球生物技術人工智慧市場、服務細分、類型、表現及預測（2019-2024、2024-2029、2034）
  • 人工智慧實施與整合服務
  • 諮詢和培訓服務
  • 雲端基礎的人工智慧解決方案
  • 維護和支援服務
  • 客製化AI模型開發

第7章 區域和國家分析

  • 全球生物技術人工智慧市場各地區、表現及預測（2019-2024、2024-2029、2034）
  • 全球生物技術人工智慧市場（按國家、表現和預測），2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 生物技術領域的人工智慧：競爭格局
  • 生物技術領域的人工智慧市場：公司簡介
    • Google LLC Overview, Products and Services, Strategy and Financial Analysis
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • International Business Machines Corporation（IBM）Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Bayer AG
  • Sanofi SA
  • Bristol-Myers Squibb Company
  • AstraZeneca Plc
  • Abbott Laboratories
  • Novartis AG
  • Roivant Sciences Ltd.
  • Gilead Sciences Inc.
  • NVIDIA Corporation
  • Amgen Inc.
  • Novo Nordisk A/S
  • Merck KGaA
  • Biogen Inc.
  • CareDx Inc.
  • Clario Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年生物技術領域的人工智慧：提供新機會的國家
  • 2029年生物技術領域的人工智慧：帶來新機會領域
  • 2029年生物技術領域的人工智慧：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r35053

Artificial intelligence (AI) in biotechnology involves the application of machine learning and data-driven algorithms to interpret biological data and accelerate scientific research. It plays a vital role in areas such as drug discovery, genomics, diagnostics, and personalized medicine by recognizing patterns and forecasting outcomes. AI improves operational efficiency, reduces research costs, and provides deeper insights into complex biological systems, fueling innovation in healthcare and life sciences.

The primary components of AI in biotechnology include software, hardware, and services. Software in this context consists of sophisticated computational tools and algorithms that analyze biological data, simulate complex biological systems, and speed up processes such as drug development, genomic analysis, and precision medicine. It supports applications such as drug discovery and development, clinical trial optimization, medical imaging, diagnostics, and more, serving end users such as pharmaceutical and biotechnology companies, academic and research institutions, healthcare providers, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and others.

The AI in biotechnology market research report is one of a series of new reports from The Business Research Company that provides AI in biotechnology market statistics, including AI in biotechnology industry global market size, regional shares, competitors with a AI in biotechnology market share, detailed AI in biotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the AI in biotechnology industry. This AI in biotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The AI in biotechnology market size has grown exponentially in recent years. It will grow from$4.46 billion in 2024 to $5.56 billion in 2025 at a compound annual growth rate (CAGR) of 24.8%. The growth during the historic period can be attributed to the rise in computational capabilities, the expansion of AI-driven drug discovery efforts, the increasing application of AI in microbiome research, the emergence of AI in regenerative medicine, and the growing adoption of AI in agricultural biotechnology.

The AI in biotechnology market size is expected to see exponential growth in the next few years. It will grow to$13.40 billion in 2029 at a compound annual growth rate (CAGR) of 24.6%. The growth in the forecast period can be attributed to the increasing adoption of AI technologies, rising investments in AI-biotech startups, growing use of AI in toxicology studies, the emergence of AI-driven predictive models in cancer research, and the expanding field of AI-driven drug repurposing. Key trends expected during this period include advancements in deep learning and neural networks, the integration of AI with genomics and proteomics, progress in AI-driven CRISPR gene editing, the use of AI in pharmacovigilance, and the development of AI-based companion diagnostics.

he growing adoption of artificial intelligence (AI) is anticipated to drive the expansion of the AI in biotechnology market. AI refers to the simulation of human cognitive functions by machines, particularly computer systems, to execute tasks such as learning, reasoning, and problem-solving. The rise in AI adoption is fueled by its ability to improve efficiency, precision, and decision-making across a wide range of industries, particularly through automating complex data analysis with high accuracy. In biotechnology, AI significantly accelerates drug discovery, streamlines research processes, and enhances predictive modeling, ultimately contributing to better healthcare outcomes. For example, in October 2024, the UK's Department for Science, Innovation & Technology (DSIT) reported a notable increase in AI activity in 2023, including a 17% rise in the number of AI companies (+543), a 34% boost in AI-generated revenue (+£3.6 billion), a 29% growth in employment (+14,500), and a nearly 57% increase in gross value added (GVA) (+£2.1 billion) compared to 2022. As a result, the expanding adoption of AI is propelling growth in the AI-driven biotechnology market.

Leading companies in the AI in biotechnology sector are prioritizing the development of advanced technologies, such as AI-powered platforms for antibody discovery, to strengthen their market position. These platforms leverage AI to efficiently identify and optimize therapeutic antibodies, accelerating drug development while reducing costs and improving clinical outcomes. For instance, in February 2023, AION Labs, a venture studio based in Israel, introduced DenovAI-an innovative platform dedicated to the de novo discovery of therapeutic antibodies. This state-of-the-art system integrates machine learning with computational biophysics to identify high-affinity antibody candidates, offering greater sequence diversity, enhanced precision, and shorter development cycles. DenovAI represents a significant leap in biotechnology, facilitating faster, more affordable drug discovery and increasing the likelihood of clinical success across various disease areas.

In February 2025, Incyte Corporation, a U.S.-based biopharmaceutical firm, entered into a strategic partnership with Genesis Therapeutics Inc. to harness the potential of AI in enhancing drug discovery efficiency. The partnership combines Incyte's deep expertise in drug development with Genesis Therapeutics' proprietary AI platform to accelerate the discovery and refinement of innovative small molecule therapies for targeted oncology treatments. Genesis Therapeutics Inc. is a U.S.-based biotechnology company that specializes in AI-powered drug discovery, aiming to revolutionize therapeutic development through advanced technological applications.

Major players in the ai in biotechnology market are Google LLC, Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., International Business Machines Corporation (IBM), Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Novartis AG, Roivant Sciences Ltd., Gilead Sciences Inc., NVIDIA Corporation, Amgen Inc., Novo Nordisk A/S, Merck KGaA, Biogen Inc., CareDx Inc., Clario Inc., BenevolentAI Limited, Recursion Pharmaceuticals Inc., Insilico Medicine Inc., and Genesis Therapeutics Inc.

North America was the largest region in the AI in biotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in AI in biotechnology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the AI in biotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The AI in biotechnology market consists of revenues earned by entities providing services such as genomics analysis, precision medicine development, biomanufacturing optimization, and AI-driven diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in biotechnology market also includes sales of bioinformatics tools, automation systems, and AI-integrated laboratory equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Biotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in biotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai in biotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ai in biotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Application: Drug Discovery And Development; Clinical Trials And Optimization; Medical Imaging; Diagnostics; Other Applications
  • 3) By End User: Pharmaceutical Companies; Biotechnology Companies; Academic And Research Institutes; Healthcare Providers; Contract Research Organization (CRO) And Contract Development And Manufacturing Organization (CDMO); Other End Users
  • Subsegments:
  • 1) By Software: AI-Powered Data Analytics Tools: Machine Learning Algorithms; Bioinformatics Software; Drug Discovery Platforms; Clinical Trial Management Software
  • 2) By Hardware: High-Performance Computing (HPC) Systems; AI-Integrated Imaging Devices: Data Storage Solutions; Laboratory Automation Equipment; Wearable Health Monitoring Devices
  • 3) By Services: AI Implementation And Integration Services; Consulting And Training Services; Cloud-Based AI Solutions; Maintenance And Support Services; Custom AI Model Development
  • Companies Mentioned: Google LLC; Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; International Business Machines Corporation (IBM)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. AI In Biotechnology Market Characteristics

3. AI In Biotechnology Market Trends And Strategies

4. AI In Biotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global AI In Biotechnology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global AI In Biotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global AI In Biotechnology Market Growth Rate Analysis
  • 5.4. Global AI In Biotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global AI In Biotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global AI In Biotechnology Total Addressable Market (TAM)

6. AI In Biotechnology Market Segmentation

  • 6.1. Global AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Hardware
  • Services
  • 6.2. Global AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery And Development
  • Clinical Trials And Optimization
  • Medical Imaging
  • Diagnostics
  • Other Applications
  • 6.3. Global AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic And Research Institutes
  • Healthcare Providers
  • Contract Research Organization (CRO) And Contract Development And Manufacturing Organization (CDMO)
  • Other End Users
  • 6.4. Global AI In Biotechnology Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • AI-Powered Data Analytics Tools
  • Machine Learning Algorithms
  • Bioinformatics Software
  • Drug Discovery Platforms
  • Clinical Trial Management Software
  • 6.5. Global AI In Biotechnology Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Performance Computing (HPC) Systems
  • AI-Integrated Imaging Devices
  • Data Storage Solutions
  • Laboratory Automation Equipment
  • Wearable Health Monitoring Devices
  • 6.6. Global AI In Biotechnology Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • AI Implementation and Integration Services
  • Consulting and Training Services
  • Cloud-Based AI Solutions
  • Maintenance and Support Services
  • Custom AI Model Development

7. AI In Biotechnology Market Regional And Country Analysis

  • 7.1. Global AI In Biotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global AI In Biotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific AI In Biotechnology Market

  • 8.1. Asia-Pacific AI In Biotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China AI In Biotechnology Market

  • 9.1. China AI In Biotechnology Market Overview
  • 9.2. China AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India AI In Biotechnology Market

  • 10.1. India AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan AI In Biotechnology Market

  • 11.1. Japan AI In Biotechnology Market Overview
  • 11.2. Japan AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia AI In Biotechnology Market

  • 12.1. Australia AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia AI In Biotechnology Market

  • 13.1. Indonesia AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea AI In Biotechnology Market

  • 14.1. South Korea AI In Biotechnology Market Overview
  • 14.2. South Korea AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe AI In Biotechnology Market

  • 15.1. Western Europe AI In Biotechnology Market Overview
  • 15.2. Western Europe AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK AI In Biotechnology Market

  • 16.1. UK AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany AI In Biotechnology Market

  • 17.1. Germany AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France AI In Biotechnology Market

  • 18.1. France AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy AI In Biotechnology Market

  • 19.1. Italy AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain AI In Biotechnology Market

  • 20.1. Spain AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe AI In Biotechnology Market

  • 21.1. Eastern Europe AI In Biotechnology Market Overview
  • 21.2. Eastern Europe AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia AI In Biotechnology Market

  • 22.1. Russia AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America AI In Biotechnology Market

  • 23.1. North America AI In Biotechnology Market Overview
  • 23.2. North America AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA AI In Biotechnology Market

  • 24.1. USA AI In Biotechnology Market Overview
  • 24.2. USA AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada AI In Biotechnology Market

  • 25.1. Canada AI In Biotechnology Market Overview
  • 25.2. Canada AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America AI In Biotechnology Market

  • 26.1. South America AI In Biotechnology Market Overview
  • 26.2. South America AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil AI In Biotechnology Market

  • 27.1. Brazil AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East AI In Biotechnology Market

  • 28.1. Middle East AI In Biotechnology Market Overview
  • 28.2. Middle East AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa AI In Biotechnology Market

  • 29.1. Africa AI In Biotechnology Market Overview
  • 29.2. Africa AI In Biotechnology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa AI In Biotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa AI In Biotechnology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. AI In Biotechnology Market Competitive Landscape And Company Profiles

  • 30.1. AI In Biotechnology Market Competitive Landscape
  • 30.2. AI In Biotechnology Market Company Profiles
    • 30.2.1. Google LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. International Business Machines Corporation (IBM) Overview, Products and Services, Strategy and Financial Analysis

31. AI In Biotechnology Market Other Major And Innovative Companies

  • 31.1. Bayer AG
  • 31.2. Sanofi S.A.
  • 31.3. Bristol-Myers Squibb Company
  • 31.4. AstraZeneca Plc
  • 31.5. Abbott Laboratories
  • 31.6. Novartis AG
  • 31.7. Roivant Sciences Ltd.
  • 31.8. Gilead Sciences Inc.
  • 31.9. NVIDIA Corporation
  • 31.10. Amgen Inc.
  • 31.11. Novo Nordisk A/S
  • 31.12. Merck KGaA
  • 31.13. Biogen Inc.
  • 31.14. CareDx Inc.
  • 31.15. Clario Inc.

32. Global AI In Biotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The AI In Biotechnology Market

34. Recent Developments In The AI In Biotechnology Market

35. AI In Biotechnology Market High Potential Countries, Segments and Strategies

  • 35.1 AI In Biotechnology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 AI In Biotechnology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 AI In Biotechnology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer